The Value Added Tax (Drugs and Medicines) Order 2023

Type Statutory-Instrument
Publication 2023-09-14
State In force
Department King's Printer of Acts of Parliament
PDF Download
articles 2
Reform history JSON API

Made: 14th September 2023

Laid before the House of Commons: 18th September 2023

Coming into force: 9th October 2023

The Treasury make this Order in exercise of the powers conferred by sections 30(4) and 96(9) of the Value Added Tax Act 1994[^f00001].

Citation, commencement and effect

1

Modification of Schedule 8 to the Value Added Tax Act 1994

2

(1A) The supply of qualifying goods to an individual where the goods are supplied to the individual— (a) for the individual’s personal use, (b) in accordance with a patient group direction issued under the Human Medicines Regulations 2012[^f00003] (S.I. 2012/1916), and (c) either— (i) by a registered pharmacist, or (ii) in accordance with a requirement or authorisation under a relevant provision.

(2E) In item 1A “patient group direction” has the meaning given in regulation 213 of the Human Medicines Regulations 2012.

Signed

Andrew Stephenson — Stuart Anderson — Two of the Lords Commissioners of His Majesty's Treasury — 14th September 2023

Explanatory note

(This note is not part of the Order)

Explanatory Note

This Order applies a temporary zero-rate of value added tax to the supply of drugs and medicines in the UK to a person for personal use in accordance with a patient group direction made under the Human Medicines Regulations 2012 (S.I. 2012/1916) for a fixed period from 9th October 2023 up to and including 31st March 2027.

Article 1 sets out the citation and commencement date of this Order, and the period for which the modifications made by the Order will have effect.

Article 2 temporarily modifies Group 12 of Schedule 8 to the Value Added Tax Act [1994 (c. 23)](https://www.legislation.gov.uk/ukpga/1994/23), so it should be read as if a new item and notes were temporarily inserted which together describe the goods supplied in accordance with a patient group direction that will attract the temporary zero-rate.

A Tax Information and Impact Note covering this instrument will be published on the government website at https://www.gov.uk/government/collections/tax-information-and-impact-notes-tiins.

Footnotes

[^f00001]: 1994 c. 23. Section 96(9) was amended by section 99(6) of, and paragraph 5 of Schedule 31 to, the Finance Act 2001 (c. 9).

[^f00002]: Group 12 was relevantly amended by paragraphs 4 and 7(a) and (c) of Schedule 7 to the Finance Act 2017 (c. 10) and paragraphs 1 and 94(1) and (5)(a) of Schedule 8 to the Taxation (Cross-border Trade) Act 2018 (c. 22). Group 12 was also amended by S.I. 1995/652, 1997/2744, 2006/1914, 2009/2972, 2012/1909 and 2013/349; there are other amending instruments but none is relevant.

[^f00003]: S.I. 2012/1916; relevant amending instruments are S.I. 2013/235, 2015/323, 2015/1503, 2016/186, 2018/199, 2018/378, 2019/775, 2020/1488, 2020/1594, 2021/1452, 2022/350 and 2022/634.

Reading this document does not replace reading the official text published on legislation.gov.uk. Contains public sector information licensed under the Open Government Licence v3.0. We assume no responsibility for any inaccuracies arising from the conversion of the original CLML XML to this format.

This text is published under legislation.gov.uk's own terms of reuse, not a Legalize or public-domain licence. legislation.gov.uk
Open Government Licence v3.0 (attribution required)
© Crown and database right. Derived from content available under the Open Government Licence v3.0 from legislation.gov.uk.